Clinical trial

Strategies in Maintenance for Patients Receiving Long-term Therapy…

NCT00446849 · Shire, Industry · Completed

Key facts

NCT number NCT00446849
Title Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC)
Official title A Phase IV, Multi-center, Open-label Study to Assess Clinical Recurrence Related to Compliance With Treatment With MMX Mesalamine 2.4g/Day Given Once Daily for the Maintenance of Quiescent Ulcerative Colitis (UC)
Lead sponsor Shire, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Ulcerative Colitis
Intervention type Drug
Interventions MMX Mesalamine
Enrollment 290
Start date May 1, 2007
Primary completion Aug 17, 2009
Completion Aug 17, 2009
First posted Mar 13, 2007
Last update posted Jun 14, 2021
Countries United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies